Tokyo, Japan

Keiji Yoshioka

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Higashiyamato, JP (2011 - 2014)
  • Tokyo, JP (2018 - 2020)

Company Filing History:


Years Active: 2011-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Keiji Yoshioka: Innovator in Glycosaminoglycan Derivatives

Introduction

Keiji Yoshioka is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of glycosaminoglycan derivatives, holding a total of 4 patents. His work focuses on the development of innovative methods and compounds that have potential applications in various physiological contexts.

Latest Patents

Yoshioka's latest patents include a groundbreaking invention related to glycosaminoglycan derivatives. The invention provides a glycosaminoglycan derivative in which a group derived from glycosaminoglycan and a group derived from a physiologically active substance, possessing at least one of a carboxy group and a hydroxy group, are coupled by a covalent bond with a spacer in between. The spacer is selected based on the decomposition rate of the covalent bond to the group derived from the physiologically active substance. This innovative approach enhances the functionality and application of glycosaminoglycan derivatives in medical and therapeutic settings.

Career Highlights

Keiji Yoshioka has established a successful career at Seikagaku Corporation, where he continues to innovate and develop new technologies. His expertise in glycosaminoglycan chemistry has positioned him as a key figure in the field. His contributions have not only advanced scientific understanding but also opened new avenues for research and application.

Collaborations

Yoshioka has collaborated with notable colleagues, including Kenji Miyamoto and Yosuke Yasuda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of innovative solutions in their field.

Conclusion

Keiji Yoshioka's work in glycosaminoglycan derivatives exemplifies the impact of innovation in science and technology. His patents and collaborations reflect a commitment to advancing knowledge and improving applications in health and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…